Skip to main content
19 January 2021
Last updated:
Sunday 17 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Göran Ando becomes chair at Nouscom

Saturday 12 December 2020
Company
Nouscom AG
Appointee Name
Göran Ando and  
Richard Davis
Country

Switzerland

Switzerland-based Nouscom AG has appointed Göran Ando as chair of its board of directors and Richard Davis as chief business officer. The appointments come as the company starts clinical development of its lead cancer vaccine. Dr Ando is currently chair of the specialty pharma company EyePoint Pharmaceuticals Inc as well as chair of Tessa Therapeutics Ltd, which is developing cell therapies for cancer. His more than 35 years in biopharma management have also included senior positions at Pfizer Inc, GlaxoSmithKline Plc and Celltech Group Ltd.

Dr Davis joins Nouscom from Johnson & Johnson Innovation. Earlier in his career he was an executive at the Wellcome Trust.

Nouscom announced the appointments on 11 December 2020.

Copyright 2020 Evernow Publishing Ltd

 

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021
Sam Herbert becomes COO at Clinigen
Wednesday January 6 2021
Wolfgang Baiker becomes CEO at Adrenomed
Wednesday January 6 2021
Alligator Bioscience appoints new CMO
Tuesday December 29 2020

© 2021 Evernow Publishing Ltd. Powered by Drupal.